Piciclib 100MG Capsule (21’s) is a targeted oral medication primarily composed of Palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This drug is specifically designed for the treatment of certain types of breast cancer, particularly hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer. By inhibiting CDK4 and CDK6, Piciclib helps to disrupt the cell cycle, thereby slowing down the proliferation of cancer cells. Each capsule contains 100 mg of Palbociclib, and it is typically prescribed in combination with aromatase inhibitors or other hormonal therapies to enhance its efficacy. The formulation is designed for easy oral administration, making it convenient for patients undergoing cancer treatment. As a part of a comprehensive cancer management plan, Piciclib plays a crucial role in improving patient outcomes and quality of life.